ABSTRACT mRNAs for isozymes of phospholipase C (PLC) were localized in rat brain by in situ hybridization with oligonucleotide probes for PLC isozymes 1, I, PLC-I may be linked to muscarinic ml and m3 receptors as well as other receptors. The distribution of PLC-II mRNA resembles that of src protooncogene, with which it displays sequence homology.
tions suggest selective coupling of individual PLC isozymes with particular postsynaptic receptors. PLC-A may be preferentially associated with 5-hydroxytryptamine IC receptors, vasopressin VI receptors, and a subtype of glutamate receptors.
PLC-I may be linked to muscarinic ml and m3 receptors as well as other receptors. The distribution of PLC-II mRNA resembles that of src protooncogene, with which it displays sequence homology.
The inositolphospholipid ("phosphoinositide"; PI) system is activated by many neurotransmitters, hormones, and growth factors through receptor-triggered hydrolysis of phosphoinositides by phospholipase C (PLC) (1, 2) . A number of distinct PLC isozymes have been differentiated (3) (4) (5) (6) (7) (8) and cDNA cloning has been completed for four of them (9) (10) (11) . Rhee and coworkers (3, 4, 9, 10) purified and cloned three isozymes, which they designated PLC-I, -II, and -III. Bennett et al. (11) cloned a fourth PLC, corresponding to the enzyme identified by Hoffman and Majerus (6) . Bennett et al. (11) have designated this enzyme PI-PLC I, but to avoid overlap with Suh et al. (9, 10) we will refer to it as PLC-A.
The multiple isozymes of PLC may reflect heterogeneity of the PI system, especially in the brain. Various isozymes of PLC might be differentially linked to the diverse neurotransmitter receptors that act through the PI cycle. In the present study we have mapped mRNA distribution for four isozymes of PLC in rat brain in situ hybridization. The striking differential localizations we observe may clarify links between isozymes of PLC, various neurotransmitter systems, and heterogeneity within the PI system.
METHODS
Oligonucleotide probes (45 bases long) were synthesized and purified by HPLC. For each isozyme three 45-base-long sequences were chosen to avoid internal repeats, regions with known homology to other sequences, and regions with greater than expected homology to rat structural RNA. For each sequence a complementary (antisense) and identical (sense) orientation probe was synthesized. For labeling reactions equal amounts of the three antisense or sense probes were mixed together.
In situ hybridization was performed using minor modifications (12) of the procedure of Young et al. (13 
RESULTS
General Properties of PLC Isozyme mRNA Labeling. Probes for the four PLC isozymes provided distinctive localizations throughout the brain (Fig. 1) . To show that label was specific we conducted several controls for each probe (Fig. 2 for PLC-A; similar data for the other probes not shown). For all four probes, negligible binding was seen with a labeled sense-strand probe. Coincubation with 100-fold excess of unlabeled antisense probe abolished antisense labeling, as did pretreatment with RNase. Melt curves for all four isozyme probes showed sharp cutoffs at appropriate melt temperatures (data not shown).
Northern (RNA) blot analysis (data not shown) for the four probes revealed discrete bands: 2 kilobases (kb) for PLC-A, a doublet of 5.4 and 7.2 kb for PLC-I, 5.3 kb for PLC-II, and 3 kb for PLC-III, corresponding to reported message lengths (9) (10) (11) . No cross hybridization with 18S or 28S RNA was seen for any of the four probes using the same high-stringency wash conditions as for the in situ experiments. Regional differences in PLC mRNA levels for each isozyme by Abbreviations: PI, inositolphospholipid ("phosphoinoside" cycle); PLC, phospholipase C; PLC-I, -II, -III, and -A, PLC types I, II, III, and A, respectively; InsP3, inositol trisphosphate; G protein, guanine nucleotide-binding regulatory protein.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. PLC mRNA in Fetal Tissue. To assess the overall distribution of the isozymes throughout the body we conducted in situ hybridization with sections of whole 19-day-old rat fetuses (Fig. 3) . Levels of PLC-A were highest overall of all the isozymes. Label was most concentrated in intestine, liver, lung, and brain, with low levels in skeletal muscle. Label was present at comparable levels in different regions of the brain, except for the choroid plexus, which was higher. By contrast, PLC-I was localized selectively in the brain, with almost undetectable levels in the liver and lung. In the developing cerebral cortex, highest levels were in the germinal zone. PLC-I was highest in the brain, especially in the cerebral cortex-particularly the germinal zone, and basal ganglia but also high in lung and present in moderate amounts in liver. Relatively low levels of PLC-Ill label were present throughout the body. These localizations generally fit with previous evidence that PLC-I is selectively localized in the brain (14) and that PLC-A occurs in various peripheral tissues with particularly high densities in the intestine, liver, and lung (11) . Similarly high levels were present in the hypothalamic supraoptic, paraventricular, and arcuate nuclei (Fig. 4 G and J). The Purkinje cell layer of the cerebellum also displayed high labeling, whereas the granule cell layer was more tightly labeled (Fig. 5C ). Moderate densities were apparent in the mitral cell layer of the olfactory bulb, the cerebral cortexespecially the pyriform cortex, the hippocampus, the median eminence, and the dorsal and median raphe nuclei. Appreciable, though lower, levels of labeling were present in regions ofthe basal forebrain, including the preoptic area, the bed nucleus ofthe stria terminalis, the anterior amygdala, and the nucleus of the lateral olfactory tract. Subdivisions of the thalamus were selectively labeled, with the ventrobasal complex most highly labeled, whereas the reticular nucleus was relatively lightly labeled. Similar levels of labeling were seen in the hypothalamus with differentiation among subdivisions. Especially highly labeled were the arcuate nucleus, the lateral hypothalamus, the ventromedial nucleus, the dorsomedial nucleus, and the tuberomammillary nucleus. Levels of label in the pineal gland were similar to the lateral hypothalamus.
PLC-I. The distribution of PLC-I differed markedly from that of PLC-A. Label was largely restricted to the forebrain. , and choroid plexus (A and P), PLC-I is especially prominent in hippocampus and dentate gyrus (H, K, and N), cerebral cortex (H, K, N, and Q), and caudate nucleus (K, N, and Q). PLC-Il was barely above background with an even distribution across brain and is not shown. Arc, arcuate nucleus; BLA, basolateral amygdala; Cb, cerebellum; Cd, caudate nucleus; CP, choroid plexus; Ctx, cerebral cortex; DG, dentate gyrus; DR, dorsal raphe nucleus; Hb, habenula; Hipp, hippocampal pyramidal; LS, lateral septum; NA, nucleus ambiguus; NDB, nucleus of the diagonal band; NLOT, nucleus of the lateral olfactory tract; OT, olfactory tubercle; Pir, pyriform cortex; POA, preoptic area; PVN, paraventricular nucleus; Re, thalamic reuniens nucleus; Rt, reticular thalamic nucleus; SON, supraoptic nucleus; VL, ventrolateral thalamic nucleus; VP, ventral pallidum; and ZI, zone incerta. (Bar = 5 mm.)
Highest densities occurred in the cerebral cortex-especially the frontal and pyriform cortex (Fig. 4 E, H, K, N, and Q) . Similar high levels were present in the caudate-putamen and ventral pallidum, whereas the adjacent globus pallidus was lightly labeled (Fig. 4 K, N, and Q) . The olfactory bulb was labeled in both the mitral cell and internal granular layers. The nucleus of the lateral olfactory tract was densely labeled, as was the nucleus of the diagonal band (Fig. 4 K and N) . Like PLC-A, PLC-I was highly concentrated in CAI through CAIV pyramidal layers of the hippocampus and granule cell layers of the dentate gyrus. PLC-I was also present in the thalamus but in different areas than PLC-A. Whereas PLC-A was localized to "specific" nuclei, PLC-I was most densely located in the "nonspecific" nuclei-particularly the reticular nucleus, the centromedian nucleus, and the nucleus reuniens. While substantial levels of PLC-A were present in the hypothalamus, only negligible levels of PLC-I were detected in hypothalamus, though there was label in the zona incerta.
Very low levels of PLC-I were seen in the hindbrain, with some detectable localization in the vagal nuclei, including the nucleus of the tractus solitarius, and in the hypoglossal nucleus. In the cerebellum, moderate levels of PLC-I occurred in the granule cell layer, but in contrast to PLC-A, there was little or no labeling of the Purkinje cell layer.
PLC-II. PLC-Il mRNA levels were lower than either PLC-A or PLC-I. PLC-Il was widely distributed, with highest levels in the mitral and internal granule cell layers of the olfactory bulb, frontal and pyriform cortex, hippocampus and dentate gyrus, and granule and Purkinje cell layers of the cerebellum. Moderate levels of label occurred in medial habenula. Overall, the density of label corresponded to neuronal packing density, with the exception of the magnocellular hypothalamic nuclei and inferior olivary nucleus of the medulla, which were not labeled more than surrounding regions.
PLC-III. PLC-III label was present at much lower levels than the other isozymes. Appreciable label was present in hippocampal pyramidal neurons in emulsion-dipped sections (data not shown). Label was evenly distributed through the rest of the brain such that it was difficult to ascertain whether the label overlay neurons or glia.
DISCUSSION
In the present study we found discrete localizations of mRNA associated with PLC-A, -I, and -II. Control experiments, including use of a labeled sense probe, coincubation of labeled antisense probe with excess unlabeled antisense probe, and pretreatment with RNase, indicate the specificity of label for all four isozymes of PLC. Our results correspond to those of Gerfen et al. (14) , who localized PLC-I and -II protein by immunohistochemistry, with the exception that enzyme protein is present in neuropil, whereas mRNA is restricted to cell bodies. Thus, for PLC-I, both mRNA and protein are strikingly localized in the reticular nucleus of the thalamus, caudate, and cerebral cortex. However, the ventrobasal thalamus contains enzyme protein in neuropil by immunohistochemistry (14) but is not labeled by in situ hybridization. For PLC-II, both protein and mRNA are widely distributed throughout the brain. While levels of protein may be regulated at both transcriptional and translational levels, these results indicate a correspondence between levels of PLC mRNA expression and abundance of protein. Our findings also correspond with previous Northern blot analysis of PLC-A expression, which revealed high concentrations in numerous peripheral tissues, including lung and intestine (11) . The explanation for the discrepancy between appreciable PLC-III Northern hybridization and low labeling by in situ hybridization is not certain. It is possible that proteins may be bound to PLC-III message in tissue and prevent access of probes for in situ hybridization but not for RNA blot hybridization (15) .
Molecular cloning of PLC-II has revealed sequence homologies to noncatalytic areas of oncogene-related tyrosine kinases, such as c-src, which may represent sites where the oncogene and PLC proteins interact with regulatory molecules (16, 17) . Our previous in situ hybridization maps of c-src mRNA in rat brain (12) resemble localizations of PLC-II, including high densities in subdivisions of the olfactory bulb, hippocampus, and granule cell layer of the cerebellum.
A number of the localizations of PLC isozymes observed here may clarify interactions of neurotransmitter systems with the PI cycle, though numerous receptors can activate PI turnover (2) , and those cited here are just selections. Within the cerebellum, PLC-A is concentrated in Purkinje cells, whereas the other PLC isozymes are present at considerably lower levels, or restricted to the granule cell layer. The major synaptic input to the Purkinje cells involves parallel fibers emanating from the granule cells, which presumably use glutamate as their neurotransmitter. Climbing-fiber input to Purkinje cells may be glutamatergic or aspartergic (18, 19) but involves receptors linked to ion channels without any known second-messenger system (20) . By contrast, the parallel-fiber glutamatergic system uses a quisqualate subtype receptor that activates PI turnover (18, 21, 35, 36) . In cerebellar slices glutamate stimulation of PI turnover is abolished in mutant mice lacking Purkinje cells (36) . We propose that PLC-A is the isozyme predominantly mediating the activation of Purkinje cells by parallel-fiber stimulation.
A quisqualate receptor-mediated enhancement of PI turnover has also been demonstrated in the hippocampus and caudate nucleus (22, 23) . Of the various isozymes, PLC-I is most prominently represented in the caudate. However, several PLC isozymes occur in both caudate and cerebral cortex. In the nucleus of the lateral olfactory tract, Nacetylaspartylglutamate, which may act in part through a quisqualate receptor (24) , is a potential activator of PI turnover.
The very high and selective concentrations of PLC-A in the choroid plexus and raphe nuclei closely resemble localizations of serotonin 1C receptors (25, 26 Several isozymes for protein kinase C have been identified and the mRNAs have been localized in rat brain by in situ hybridization (34) . Localizations ofPLC-I and protein kinase C types II and III are similar-high concentrations occur in cortex, caudate, the nucleus of the lateral olfactory tract, the granule layer of the cerebellum, and the hippocampus. PLC-A and protein kinase C type I are both selectively localized to Purkinje cells of the cerebellum. These localizations suggest that PI signaling by PLC-A in the cerebellum may preferentially activate protein kinase C type I, whereas PLC-I may be coordinated with protein kinase C types II and III.
Note Added in Proof. Rhee et al. (37) have recently proposed a consistent nomenclature for the PLC isozymes. Under this system our PLC-A corresponds to their PLC a, our PLC-I corresponds to PLC f3, PLC-II corresponds to PLC y, and PLC-Ill corresponds to PLC 6.
